文献速递肿瘤 PET/CT

68Ga-FAPI PET/CT 鉴别鳞状细胞肺癌患者反应性淋巴结与肿瘤转移性淋巴结

Differentiation of Reactive Lymph Nodes and Tumor Metastatic Lymph Nodes With 68Ga-FAPI PET/CT in a Patient With Squamous Cell Lung Cancer.
PubMed 文献 · Clin Nucl Med · 2022-01-01

本文报道一例鳞状细胞肺癌患者的 18F-FDG 与 68Ga-FAPI PET/CT 表现:18F-FDG PET/CT 因肿大右下部气管旁淋巴结摄取增高判定为 IIIA 期(T1bN2M0),而该淋巴结未见异常 68Ga-FAPI 摄取;后续组织病理学检查示纵隔淋巴结无恶性证据,肿瘤分期降为 IA 期(T1bN0M0),与基于 68Ga-FAPI 的 TNM 分期一致。

要点

  • 18F-FDG PET/CT 因右下部气管旁淋巴结摄取增高判为 IIIA 期(T1bN2M0)。
  • 该淋巴结未见异常 68Ga-FAPI 摄取。
  • 组织病理学示纵隔淋巴结无恶性证据,分期降为 IA 期(T1bN0M0)。

核心结论

  • 该例中 68Ga-FAPI PET/CT 未见异常摄取的纵隔淋巴结经组织病理学证实无恶性证据,基于 68Ga-FAPI 的 TNM 分期与降期后的 IA 期(T1bN0M0)一致。

研究设计与样本

  • 本文为病例报告,报道一例鳞状细胞肺癌患者的 18F-FDG 与 68Ga-FAPI PET/CT 表现。

主要发现

  • 18F-FDG PET/CT 因肿大右下部气管旁淋巴结摄取增高,判定为 IIIA 期(T1bN2M0)。
  • 该淋巴结未见异常 68Ga-FAPI 摄取。
  • 后续组织病理学检查示纵隔淋巴结无恶性证据,肿瘤分期降为 IA 期(T1bN0M0)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

False-positive findings of mediastinal lymph node often confound the image interpretation of the preoperative PET/CT in non-small cell lung cancer. In this case, we reported 18F-FDG and 68Ga-FAPI PET/CT findings in a patient with squamous cell lung cancer. 18F-FDG-based TNM stage was stage IIIA (T1bN2M0) due to increased uptake in the enlarged right lower paratracheal lymph node. However, no abnormal 68Ga-FAPI uptake was observed in this lymph node. Subsequent histopathological examination revealed no evidence of malignancy in the mediastinal lymph nodes. Therefore, the tumor stage was downstaged to stage IA (T1bN0M0), which was in accordance with 68Ga-FAPI-based TNM stage.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Shang Q, Zhao L, Pang Y, et al. Differentiation of Reactive Lymph Nodes and Tumor Metastatic Lymph Nodes With 68Ga-FAPI PET/CT in a Patient With Squamous Cell Lung Cancer. Clin Nucl Med. 2022. PMID: 35020643. doi:10.1097/RLU.0000000000003998

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。